{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:24:39Z","timestamp":1781223879070,"version":"3.54.1"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T00:00:00Z","timestamp":1191888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1744-859x-6-27","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T06:13:15Z","timestamp":1191996795000},"source":"Crossref","is-referenced-by-count":57,"title":["Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder"],"prefix":"10.1186","volume":"6","author":[{"given":"Konstantinos N","family":"Fountoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Siamouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatia","family":"Magiria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timucin","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fresno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panteleimon","family":"Giannakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S","family":"Kaprinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,9]]},"reference":[{"issue":"7","key":"584_CR1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v64n0717","volume":"64","author":"RM Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW: The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry. 2003, 64 (7): 841-846.","journal-title":"J Clin Psychiatry"},{"key":"584_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-0327(98)00142-6","volume":"50","author":"J Angst","year":"1998","unstructured":"Angst J: The emerging epidemiology of hypomania and bipolar II disorder. Journal of Affective Disorders. 1998, 50: 143-151. 10.1016\/S0165-0327(98)00142-6.","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"584_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000082021","volume":"74","author":"E Vieta","year":"2005","unstructured":"Vieta E, Carne X: The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosom. 2005, 74 (1): 10-16. 10.1159\/000082021.","journal-title":"Psychother Psychosom"},{"key":"584_CR4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archpsyc.1991.01810360046007","volume":"48","author":"T Suppes","year":"1991","unstructured":"Suppes T, Baldessarini RJ, Faedda GL, Tohen M: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry. 1991, 48: 1082-1088.","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"584_CR5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/ajp.148.9.1237","volume":"148","author":"GL Faedda","year":"1991","unstructured":"Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C: Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry. 1991, 148 (9): 1237-1239.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"584_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF00441955","volume":"98","author":"M Maj","year":"1988","unstructured":"Maj M, Priozzi R, Kemali D: Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berl). 1988, 98 (4): 535-538. 10.1007\/BF00441955.","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"584_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00004850-198910000-00006","volume":"4","author":"JB Cohn","year":"1989","unstructured":"Cohn JB, Collins G, Ashbrook E, Wernicke JF: A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol. 1989, 4 (4): 313-322. 10.1097\/00004850-198910000-00006.","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"584_CR8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.v60n0503","volume":"60","author":"AJ Rush","year":"1999","unstructured":"Rush AJ, Rago WV, Crismon ML, Toprac MG, Shon SP, Suppes T, Miller AL, Trivedi MH, Swann AC, Biggs MM, Shores-Wilson K, Kashner TM, Pigott T, Chiles JA, Gilbert DA, Altshuler KZ: Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. J Clin Psychiatry. 1999, 60 (5): 284-291.","journal-title":"J Clin Psychiatry"},{"key":"584_CR9","unstructured":"Expert consensus guidelines are released for the treatment of bipolar disorder. Consensus Development Conferences. Am Fam Physician. 1997, 55 (4): 1447-1449."},{"issue":"1","key":"584_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00004583-199701000-00032","volume":"36","author":"AACAP","year":"1997","unstructured":"AACAP: AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 1997, 36 (1): 138-157.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"584_CR11","first-page":"1","volume-title":"Postgrad Med","author":"MH Allen","year":"2001","unstructured":"Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP: The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med. 2001, 1-88; quiz 89-90."},{"issue":"12 Suppl","key":"584_CR12","first-page":"1","volume":"151","author":"APA","year":"1994","unstructured":"APA: Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Am J Psychiatry. 1994, 151 (12 Suppl): 1-36.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"584_CR13","first-page":"1605","volume":"51","author":"APA","year":"1995","unstructured":"APA: American Psychiatric Association releases treatment guideline for bipolar disease. Am Fam Physician. 1995, 51 (6): 1605-1606.","journal-title":"Am Fam Physician"},{"issue":"4 Suppl","key":"584_CR14","first-page":"1","volume":"159","author":"American Psychiatric Association","year":"2002","unstructured":"American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002, 159 (4 Suppl): 1-50.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"584_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/hrp\/7.4.230","volume":"7","author":"P Barreira","year":"1999","unstructured":"Barreira P, Duckworth K, Goff D, Flannery RB: Clinical practice guidelines: the Massachusetts experience in psychiatry. Harv Rev Psychiatry. 1999, 7 (4): 230-232. 10.1093\/hrp\/7.4.230.","journal-title":"Harv Rev Psychiatry"},{"issue":"7","key":"584_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4088\/JCP.v59n0702","volume":"59","author":"DA Gilbert","year":"1998","unstructured":"Gilbert DA, Altshuler KZ, Rago WV, Shon SP, Crismon ML, Toprac MG, Rush AJ: Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. J Clin Psychiatry. 1998, 59 (7): 345-351.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"584_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11920-000-0074-7","volume":"2","author":"EB Dennehy","year":"2000","unstructured":"Dennehy EB: Guidelines for treatment of bipolar disorder. Curr Psychiatry Rep. 2000, 2 (4): 316-321. 10.1007\/s11920-000-0074-7.","journal-title":"Curr Psychiatry Rep"},{"key":"584_CR18","first-page":"12","volume":"61 Supp 13","author":"JF Goldberg","year":"2000","unstructured":"Goldberg JF: Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry. 2000, 61 Supp 13: 12-18.","journal-title":"J Clin Psychiatry"},{"key":"584_CR19","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.3109\/13651509709024750","volume":"1","author":"GM Goodwin","year":"1997","unstructured":"Goodwin GM, Bourgeois MI, Conti L: Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatry Clin Pract. 1997, 1: S9-S12.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"2","key":"584_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/0269881103017002003","volume":"17","author":"GM Goodwin","year":"2003","unstructured":"Goodwin GM: Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003, 17 (2): 149-73; discussion 147. 10.1177\/0269881103017002003.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"584_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/15622970209150612","volume":"3","author":"H Grunze","year":"2002","unstructured":"Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, Vieta E, Moller HJ: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry. 2002, 3 (3): 115-124.","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"584_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970309167904","volume":"4","author":"H Grunze","year":"2003","unstructured":"Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, Vieta E, Moller HJ: The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry. 2003, 4 (1): 5-13.","journal-title":"World J Biol Psychiatry"},{"key":"584_CR23","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3109\/13651509709024748","volume":"1","author":"K Jobson","year":"1997","unstructured":"Jobson K: International Psychopharmacology Algorithm Project: Algorithms in psychopharmacology. Int J Psychiatry Clin Pract. 1997, 1: S3-S8.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"584_CR24","volume-title":"Bipolar disorder: a summary of clinical issues and treatment options","author":"V Kusumakar","year":"1997","unstructured":"Kusumakar V, Yatham LN, Parikh SV: Bipolar disorder: a summary of clinical issues and treatment options. 1997, Halifax, Nova Scotia: CANMAT Monograph"},{"key":"584_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0447.108.s419.1.x","volume":"419","author":"RW Licht","year":"2003","unstructured":"Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH, Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark: Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl. 2003, 419: 1-22. 10.1034\/j.1600-0447.108.s419.1.x.","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"10 Suppl","key":"584_CR26","first-page":"157S","volume":"36","author":"J McClellan","year":"1997","unstructured":"McClellan J, Werry J: Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997, 36 (10 Suppl): 157S-76S.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"584_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0924-977X(00)00140-1","volume":"11","author":"DB Montgomery","year":"2001","unstructured":"Montgomery DB: ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol. 2001, 11 (1): 79-88. 10.1016\/S0924-977X(00)00140-1.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"584_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v64n0402","volume":"64","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte BP, Shon SP, Rago WV, Altshuler KZ: Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry. 2003, 64 (4): 357-369.","journal-title":"J Clin Psychiatry"},{"key":"584_CR29","first-page":"1","volume":"Spec No","author":"GS Sachs","year":"2000","unstructured":"Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med. 2000, Spec No: 1-104.","journal-title":"Postgrad Med"},{"issue":"3","key":"584_CR30","first-page":"469","volume":"31","author":"T Suppes","year":"1995","unstructured":"Suppes T, Calabrese JR, Mitchell PB, Pazzaglia PJ, Potter WZ, Zarin DA: Algorithms for the treatment of bipolar manic-depressive illness. Psychopharmacol Bull. 1995, 31 (3): 469-474.","journal-title":"Psychopharmacol Bull"},{"issue":"4","key":"584_CR31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v63n0404","volume":"63","author":"T Suppes","year":"2002","unstructured":"Suppes T, Dennehy EB, Swann AC, Bowden CL, Calabrese JR, Hirschfeld RM, Keck PE, Sachs GS, Crismon ML, Toprac MG, Shon SP: Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry. 2002, 63 (4): 288-299.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"584_CR32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.v64n0403","volume":"64","author":"T Suppes","year":"2003","unstructured":"Suppes T, Rush AJ, Dennehy EB, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Brown ES, Biggs MM, Shores-Wilson K, Witte BP, Trivedi MH, Miller AL, Altshuler KZ, Shon SP: Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry. 2003, 64 (4): 370-382.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"584_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4088\/JCP.v62n0607","volume":"62","author":"T Suppes","year":"2001","unstructured":"Suppes T, Swann AC, Dennehy EB, Habermacher ED, Mason M, Crismon ML, Toprac MG, Rush AJ, Shon SP, Altshuler KZ: Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry. 2001, 62 (6): 439-447.","journal-title":"J Clin Psychiatry"},{"issue":"7561","key":"584_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bmj.333.7561.220","volume":"333","author":"A O'Dowd","year":"2006","unstructured":"O'Dowd A: NICE issues new guidance to improve the treatment of bipolar disorder. Bmj. 2006, 333 (7561): 220-10.1136\/bmj.333.7561.220.","journal-title":"Bmj"},{"key":"584_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","volume":"7 Suppl 3","author":"LN Yatham","year":"2005","unstructured":"Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP: Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005, 7 Suppl 3: 5-69.","journal-title":"Bipolar Disord"},{"issue":"3","key":"584_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/15622970410029924","volume":"5","author":"H Grunze","year":"2004","unstructured":"Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry. 2004, 5 (3): 120-135. 10.1080\/15622970410029924.","journal-title":"World J Biol Psychiatry"},{"issue":"6","key":"584_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","volume":"8","author":"LN Yatham","year":"2006","unstructured":"Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S: Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006, 8 (6): 721-739. 10.1111\/j.1399-5618.2006.00432.x.","journal-title":"Bipolar Disord"},{"issue":"suppl12A","key":"584_CR38","first-page":"1","volume":"57","author":"AJ Frances","year":"1996","unstructured":"Frances AJ, Docherty JP, Kahn DA: The Expert Consensus Guideline Series: Treatment of Bipolar Disorder. J Clin Psychiatry. 1996, 57 (suppl12A): 1-88.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"584_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v60n0104","volume":"60","author":"MS Bauer","year":"1999","unstructured":"Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, Wittlin B, Powell BJ: Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry. 1999, 60 (1): 9-21.","journal-title":"J Clin Psychiatry"},{"key":"584_CR40","volume-title":"Guideline Watch for the Practice Guideline for the Treatment of Patients With Bipolar Disorder","author":"RMA Hirschfeld","year":"2005","unstructured":"Hirschfeld RMA: Guideline Watch for the Practice Guideline for the Treatment of Patients With Bipolar Disorder. 2005, Arlington, VA , American Psychiatric Association"},{"key":"584_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-5618.2005.00221.x","volume":"7 Suppl 3","author":"E Vieta","year":"2005","unstructured":"Vieta E, Nolen WA, Grunze H, Licht RW, Goodwin G: A European perspective on the Canadian guidelines for bipolar disorder. Bipolar Disord. 2005, 7 Suppl 3: 73-76.","journal-title":"Bipolar Disord"},{"issue":"1","key":"584_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2005.01.004","volume":"86","author":"KN Fountoulakis","year":"2005","unstructured":"Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS: Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005, 86 (1): 1-10. 10.1016\/j.jad.2005.01.004.","journal-title":"J Affect Disord"},{"issue":"2","key":"584_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","volume":"161","author":"JR Geddes","year":"2004","unstructured":"Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM: Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004, 161 (2): 217-222. 10.1176\/appi.ajp.161.2.217.","journal-title":"Am J Psychiatry"},{"key":"584_CR44","first-page":"44","volume":"64 Suppl 5","author":"RJ Baldessarini","year":"2003","unstructured":"Baldessarini RJ, Tondo L, Hennen J: Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry. 2003, 64 Suppl 5: 44-52.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"584_CR45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.biopsych.2006.02.034","volume":"59","author":"JR Calabrese","year":"2006","unstructured":"Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R, DeVeaugh-Geiss A, Thompson TR: Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry. 2006, 59 (11): 1061-1064. 10.1016\/j.biopsych.2006.02.034.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"584_CR46","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/archpsyc.1983.01790220086014","volume":"41","author":"RF Prien","year":"1984","unstructured":"Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE: Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry. 1984, 41 (11): 1096-1104.","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"584_CR47","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archpsyc.1982.04290090053011","volume":"39","author":"JM Kane","year":"1982","unstructured":"Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A: Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry. 1982, 39 (9): 1065-1069.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"584_CR48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.271.12.918","volume":"271","author":"CL Bowden","year":"1994","unstructured":"Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG: Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994, 271 (12): 918-924. 10.1001\/jama.271.12.918.","journal-title":"JAMA"},{"issue":"8","key":"584_CR49","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/archpsyc.62.8.860","volume":"62","author":"LV Kessing","year":"2005","unstructured":"Kessing LV, Sondergard L, Kvist K, Andersen PK: Suicide risk in patients treated with lithium. Arch Gen Psychiatry. 2005, 62 (8): 860-866. 10.1001\/archpsyc.62.8.860.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"584_CR50","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","volume":"162","author":"A Cipriani","year":"2005","unstructured":"Cipriani A, Pretty H, Hawton K, Geddes JR: Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005, 162 (10): 1805-1819. 10.1176\/appi.ajp.162.10.1805.","journal-title":"Am J Psychiatry"},{"key":"584_CR51","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0924-977X(03)00079-8","volume":"13 Suppl 2","author":"JR Calabrese","year":"2003","unstructured":"Calabrese JR, Vieta E, Shelton MD: Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol. 2003, 13 Suppl 2: S57-66. 10.1016\/S0924-977X(03)00079-8.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"584_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/00023210-200418010-00007","volume":"18","author":"DR Goldsmith","year":"2004","unstructured":"Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM: Spotlight on lamotrigine in bipolar disorder. CNS Drugs. 2004, 18 (1): 63-67. 10.2165\/00023210-200418010-00007.","journal-title":"CNS Drugs"},{"key":"584_CR53","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1176\/ajp.149.12.1727","volume":"149","author":"RM Post","year":"1992","unstructured":"Post RM, Leverich GS, Altshuler L, Mikalauskas K: Lithium-discontinuation-induced refractoriness: Preliminary observations. Am J Psychiatry. 1992, 149: 1727-","journal-title":"Am J Psychiatry"},{"issue":"5","key":"584_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","volume":"57","author":"CL Bowden","year":"2000","unstructured":"Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Chou JC, Keck PE, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ: A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry. 2000, 57 (5): 481-489. 10.1001\/archpsyc.57.5.481.","journal-title":"Arch Gen Psychiatry"},{"key":"584_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1744-859X-4-14","volume":"4","author":"PH Silverstone","year":"2005","unstructured":"Silverstone PH, Bell EC, Willson MC, Dave S, Wilman AH: Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: an fMRI study. Ann Gen Psychiatry. 2005, 4: 14-10.1186\/1744-859X-4-14.","journal-title":"Ann Gen Psychiatry"},{"issue":"11","key":"584_CR56","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","volume":"162","author":"JR Calabrese","year":"2005","unstructured":"Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL: A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. 2005, 162 (11): 2152-2161. 10.1176\/appi.ajp.162.11.2152.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"584_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","volume":"85","author":"LL Davis","year":"2005","unstructured":"Davis LL, Bartolucci A, Petty F: Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord. 2005, 85 (3): 259-266. 10.1016\/j.jad.2004.09.009.","journal-title":"J Affect Disord"},{"issue":"1","key":"584_CR58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","volume":"48","author":"HG Pope Jr.","year":"1991","unstructured":"Pope HG, McElroy SL, Keck PE, Hudson JI: Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry. 1991, 48 (1): 62-68.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"584_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","volume":"6","author":"G Sachs","year":"2004","unstructured":"Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, Sweitzer DE: Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2004, 6 (3): 213-223. 10.1111\/j.1399-5618.2004.00115.x.","journal-title":"Bipolar Disord"},{"issue":"6","key":"584_CR60","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","volume":"159","author":"M Tohen","year":"2002","unstructured":"Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA: Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry. 2002, 159 (6): 1011-1017. 10.1176\/appi.ajp.159.6.1011.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"584_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/01.jcp.0000145342.38170.7f","volume":"24","author":"JA Welge","year":"2004","unstructured":"Welge JA, Keck PE, Meinhold JM: Predictors of response to treatment of acute bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trials. J Clin Psychopharmacol. 2004, 24 (6): 607-612. 10.1097\/01.jcp.0000145342.38170.7f.","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"584_CR62","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","volume":"67","author":"CL Bowden","year":"2006","unstructured":"Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, Abi-Saab W, Saltarelli M: A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry. 2006, 67 (10): 1501-1510.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"584_CR63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","volume":"149","author":"TW Freeman","year":"1992","unstructured":"Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC: A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992, 149 (1): 108-111.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"584_CR64","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00004714-199308000-00009","volume":"13","author":"JR Calabrese","year":"1993","unstructured":"Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ: Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol. 1993, 13 (4): 280-283. 10.1097\/00004714-199308000-00009.","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"584_CR65","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","volume":"28","author":"L Gyulai","year":"2003","unstructured":"Gyulai L, Bowden CL, McElroy SL, Calabrese JR, Petty F, Swann AC, Chou JC, Wassef A, Risch CS, Hirschfeld RM, Nemeroff CB, Keck PE, Evans DL, Wozniak PJ: Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003, 28 (7): 1374-1382. 10.1038\/sj.npp.1300190.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"584_CR66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0165-0327(84)90013-2","volume":"6","author":"S Puzynski","year":"1984","unstructured":"Puzynski S, Klosiewicz L: Valproic acid amide in the treatment of affective and schizoaffective disorders. J Affect Disord. 1984, 6 (1): 115-121. 10.1016\/0165-0327(84)90013-2.","journal-title":"J Affect Disord"},{"issue":"3","key":"584_CR67","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.v58n0301","volume":"58","author":"DA Solomon","year":"1997","unstructured":"Solomon DA, Ryan CE, Keitner GI, Miller IW, Shea MT, Kazim A, Keller MB: A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry. 1997, 58 (3): 95-99.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"584_CR68","first-page":"89","volume":"48","author":"B Lerer","year":"1987","unstructured":"Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S: Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry. 1987, 48 (3): 89-93.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"584_CR69","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","volume":"26","author":"ME Thase","year":"2006","unstructured":"Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR: Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006, 26 (6): 600-609. 10.1097\/01.jcp.0000248603.76231.b7.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"584_CR70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","volume":"65","author":"RH Weisler","year":"2004","unstructured":"Weisler RH, Kalali AH, Ketter TA: A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry. 2004, 65 (4): 478-484.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"584_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1358\/dot.2006.42.5.985635","volume":"42","author":"RT Owen","year":"2006","unstructured":"Owen RT: Extended-release carbamazepine for acute bipolar mania: a review. Drugs Today (Barc). 2006, 42 (5): 283-289. 10.1358\/dot.2006.42.5.985635.","journal-title":"Drugs Today (Barc)"},{"issue":"7","key":"584_CR72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.137.7.782","volume":"137","author":"JC Ballenger","year":"1980","unstructured":"Ballenger JC, Post RM: Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry. 1980, 137 (7): 782-790.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"584_CR73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/ajp.143.1.29","volume":"143","author":"RM Post","year":"1986","unstructured":"Post RM, Uhde TW, Roy-Byrne PP, Joffe RT: Antidepressant effects of carbamazepine. Am J Psychiatry. 1986, 143 (1): 29-34.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"584_CR74","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4088\/JCP.v64n0206","volume":"64","author":"EG Hartong","year":"2003","unstructured":"Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA: Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry. 2003, 64 (2): 144-151.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"584_CR75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","volume":"58","author":"KD Denicoff","year":"1997","unstructured":"Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM: Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 1997, 58 (11): 470-478.","journal-title":"J Clin Psychiatry"},{"key":"584_CR76","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2007-1014301","volume":"27","author":"J Fritze","year":"1994","unstructured":"Fritze J, Beneke M, Lanczik M, Schneider B, Walden J: Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders. Pharmacopsychiatry. 1994, 27: 181-","journal-title":"Pharmacopsychiatry"},{"key":"584_CR77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00004714-199812000-00007","volume":"18","author":"W Greil","year":"1998","unstructured":"Greil W, Kleindienst N, Erazo N, Muller-Oerlinghausen B: Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol. 1998, 18: 455-10.1097\/00004714-199812000-00007.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"584_CR78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-0447.1992.tb01453.x","volume":"85","author":"N Coxhead","year":"1992","unstructured":"Coxhead N, Silverstone T, Cookson J: Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand. 1992, 85 (2): 114-118. 10.1111\/j.1600-0447.1992.tb01453.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"12","key":"584_CR79","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1176\/ajp.140.12.1602","volume":"140","author":"RM Post","year":"1983","unstructured":"Post RM, Uhde TW, Ballenger JC, Squillace KM: Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry. 1983, 140 (12): 1602-1604.","journal-title":"Am J Psychiatry"},{"key":"584_CR80","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1192\/bjp.150.2.180","volume":"150","author":"SE Watkins","year":"1987","unstructured":"Watkins SE, Callender K, Thomas DR, Tidmarsh SF, Shaw DM: The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry. 1987, 150: 180-182.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"584_CR81","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0165-0327(96)01427-9","volume":"43","author":"W Greil","year":"1997","unstructured":"Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Muller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T: Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study. J Affect Disord. 1997, 43 (2): 151-161. 10.1016\/S0165-0327(96)01427-9.","journal-title":"J Affect Disord"},{"key":"584_CR82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000054844","volume":"42 Suppl 1","author":"N Kleindienst","year":"2000","unstructured":"Kleindienst N, Greil W: Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology. 2000, 42 Suppl 1: 2-10. 10.1159\/000054844.","journal-title":"Neuropsychobiology"},{"key":"584_CR83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-198611030-00001","volume":"11","author":"L Bertilsson","year":"1986","unstructured":"Bertilsson L, Tomson T: Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine 10,11-epoxide: An update. Clin Pharmacokinet. 1986, 11: 177-","journal-title":"Clin Pharmacokinet"},{"key":"584_CR84","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/j.1875-9114.1998.tb03148.x","volume":"18","author":"SC Blackburn","year":"1998","unstructured":"Blackburn SC, Oliart AD, Garcia Rodriguez LA, Perez Gutthann S: Antiepileptics and blood dyscrasias: A cohort study. Pharmacotherapy. 1998, 18: 1277-","journal-title":"Pharmacotherapy"},{"issue":"11","key":"584_CR85","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4088\/JCP.v67n1112","volume":"67","author":"RH Perlis","year":"2006","unstructured":"Perlis RH, Baker RW, Zarate CA, Brown EB, Schuh LM, Jamal HH, Tohen M: Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry. 2006, 67 (11): 1747-1753.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"584_CR86","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","volume":"60","author":"CL Bowden","year":"2003","unstructured":"Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003, 60 (4): 392-400. 10.1001\/archpsyc.60.4.392.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"584_CR87","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","volume":"67","author":"EB Brown","year":"2006","unstructured":"Brown EB, McElroy SL, Keck PE, Deldar A, Adams DH, Tohen M, Williamson DJ: A 7-week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry. 2006, 67 (7): 1025-1033.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"584_CR88","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","volume":"64","author":"JR Calabrese","year":"2003","unstructured":"Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003, 64 (9): 1013-1024.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"584_CR89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","volume":"60","author":"JR Calabrese","year":"1999","unstructured":"Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999, 60 (2): 79-88.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"584_CR90","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","volume":"61","author":"JR Calabrese","year":"2000","unstructured":"Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET: A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000, 61 (11): 841-850.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"584_CR91","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","volume":"65","author":"GM Goodwin","year":"2004","unstructured":"Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R: A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004, 65 (3): 432-441.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"584_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1009066725103","volume":"12","author":"L Ichim","year":"2000","unstructured":"Ichim L, Berk M, Brook S: Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry. 2000, 12 (1): 5-10. 10.1023\/A:1009066725103.","journal-title":"Ann Clin Psychiatry"},{"issue":"2","key":"584_CR93","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4088\/JCP.v65n0210","volume":"65","author":"SL McElroy","year":"2004","unstructured":"McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J: A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. J Clin Psychiatry. 2004, 65 (2): 204-210.","journal-title":"J Clin Psychiatry"},{"issue":"3 Pt 2","key":"584_CR94","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","volume":"2","author":"AC Pande","year":"2000","unstructured":"Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G: Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000, 2 (3 Pt 2): 249-255. 10.1034\/j.1399-5618.2000.20305.x.","journal-title":"Bipolar Disord"},{"issue":"3","key":"584_CR95","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4088\/JCP.v67n0320","volume":"67","author":"E Vieta","year":"2006","unstructured":"Vieta E, Manuel Goikolea J, Martinez-Aran A, Comes M, Verger K, Masramon X, Sanchez-Moreno J, Colom F: A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. J Clin Psychiatry. 2006, 67 (3): 473-477.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"584_CR96","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1034\/j.1399-5618.2002.01211.x","volume":"4","author":"PW Wang","year":"2002","unstructured":"Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA: Gabapentin augmentation therapy in bipolar depression. Bipolar Disord. 2002, 4 (5): 296-301. 10.1034\/j.1399-5618.2002.01211.x.","journal-title":"Bipolar Disord"},{"issue":"1","key":"584_CR97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","volume":"8","author":"SF Kushner","year":"2006","unstructured":"Kushner SF, Khan A, Lane R, Olson WH: Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord. 2006, 8 (1): 15-27. 10.1111\/j.1399-5618.2006.00276.x.","journal-title":"Bipolar Disord"},{"issue":"4","key":"584_CR98","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","volume":"67","author":"RH Perlis","year":"2006","unstructured":"Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE: Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry. 2006, 67 (4): 509-516.","journal-title":"J Clin Psychiatry"},{"key":"584_CR99","first-page":"CD004043","volume-title":"Cochrane Database Syst Rev","author":"JM Rendell","year":"2006","unstructured":"Rendell JM, Gijsman HJ, Bauer MS, Goodwin GM, Geddes GR: Risperidone alone or in combination for acute mania. Cochrane Database Syst Rev. 2006, CD004043-"},{"issue":"8","key":"584_CR100","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4088\/JCP.v66n0809","volume":"66","author":"S Gopal","year":"2005","unstructured":"Gopal S, Steffens DC, Kramer ML, Olsen MK: Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. J Clin Psychiatry. 2005, 66 (8): 1016-1020.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"584_CR101","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","volume":"161","author":"RM Hirschfeld","year":"2004","unstructured":"Hirschfeld RM, Keck PE, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F: Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry. 2004, 161 (6): 1057-1065. 10.1176\/appi.ajp.161.6.1057.","journal-title":"Am J Psychiatry"},{"key":"584_CR102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1192\/bjp.187.3.229","volume":"187","author":"S Khanna","year":"2005","unstructured":"Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M: Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry. 2005, 187: 229-234. 10.1192\/bjp.187.3.229.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"584_CR103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","volume":"163","author":"AA Nierenberg","year":"2006","unstructured":"Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS: Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006, 163 (2): 210-216. 10.1176\/appi.ajp.163.2.210.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"584_CR104","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"GS Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL: Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002, 159 (7): 1146-1154. 10.1176\/appi.ajp.159.7.1146.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"584_CR105","first-page":"176","volume":"21","author":"J Segal","year":"1998","unstructured":"Segal J, Berk M, Brook S: Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol. 1998, 21 (3): 176-180.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"584_CR106","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","volume":"15","author":"AB Smulevich","year":"2005","unstructured":"Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F: Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol. 2005, 15 (1): 75-84. 10.1016\/j.euroneuro.2004.06.003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"584_CR107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1192\/bjp.182.2.141","volume":"182","author":"LN Yatham","year":"2003","unstructured":"Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A: Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry. 2003, 182: 141-147. 10.1192\/bjp.182.2.141.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"584_CR108","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00004714-200304000-00005","volume":"23","author":"RW Baker","year":"2003","unstructured":"Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, Stauffer VL, Shao L, Tollefson GD: Acute dysphoric mania: treatment response to olanzapine versus placebo. J Clin Psychopharmacol. 2003, 23 (2): 132-137. 10.1097\/00004714-200304000-00005.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"584_CR109","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/01.jcp.0000085410.08426.9a","volume":"23","author":"RJ Baldessarini","year":"2003","unstructured":"Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE, McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate CA, Baker RW, Tohen M: Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol. 2003, 23 (4): 370-376. 10.1097\/01.jcp.0000085410.08426.9a.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"584_CR110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00004850-199911000-00003","volume":"14","author":"M Berk","year":"1999","unstructured":"Berk M, Ichim L, Brook S: Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol. 1999, 14 (6): 339-343. 10.1097\/00004850-199911000-00003.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"584_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1399-5618.2003.02237.x","volume":"5","author":"KN Chengappa","year":"2003","unstructured":"Chengappa KN, Baker RW, Shao L, Yatham LN, Tohen M, Gershon S, Kupfer DJ: Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord. 2003, 5 (1): 1-5. 10.1034\/j.1399-5618.2003.02237.x.","journal-title":"Bipolar Disord"},{"issue":"5","key":"584_CR112","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4088\/JCP.v67n0514","volume":"67","author":"SA Corya","year":"2006","unstructured":"Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF: A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. J Clin Psychiatry. 2006, 67 (5): 798-806.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"584_CR113","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4088\/JCP.v67n0811","volume":"67","author":"JP Houston","year":"2006","unstructured":"Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ: Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. J Clin Psychiatry. 2006, 67 (8): 1246-1252.","journal-title":"J Clin Psychiatry"},{"key":"584_CR114","volume-title":"J Psychiatr Res","author":"JP Houston","year":"2005","unstructured":"Houston JP, Lipkovich IA, Ahl J, Rotelli MD, Baker RW, Bowden CL: Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: Post hoc analysis of patients treated with olanzapine or lithium. J Psychiatr Res. 2005"},{"issue":"4","key":"584_CR115","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","volume":"21","author":"K Meehan","year":"2001","unstructured":"Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A: A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol. 2001, 21 (4): 389-397. 10.1097\/00004714-200108000-00006.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"584_CR116","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0149-2918(04)90013-6","volume":"26","author":"L Shi","year":"2004","unstructured":"Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, Tohen M: Effects of olanzapine alone and olanzapine\/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clin Ther. 2004, 26 (1): 125-134. 10.1016\/S0149-2918(04)90013-6.","journal-title":"Clin Ther"},{"issue":"1-3","key":"584_CR117","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jad.2005.07.011","volume":"89","author":"T Suppes","year":"2005","unstructured":"Suppes T, Brown E, Schuh LM, Baker RW, Tohen M: Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. J Affect Disord. 2005, 89 (1-3): 69-77. 10.1016\/j.jad.2005.07.011.","journal-title":"J Affect Disord"},{"issue":"2","key":"584_CR118","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","volume":"163","author":"M Tohen","year":"2006","unstructured":"Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL: Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry. 2006, 163 (2): 247-256. 10.1176\/appi.ajp.163.2.247.","journal-title":"Am J Psychiatry"},{"key":"584_CR119","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1192\/bjp.184.4.337","volume":"184","author":"M Tohen","year":"2004","unstructured":"Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR: Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry. 2004, 184: 337-345. 10.1192\/bjp.184.4.337.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"584_CR120","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"M Tohen","year":"2002","unstructured":"Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A: Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002, 59 (1): 62-69. 10.1001\/archpsyc.59.1.62.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"584_CR121","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, Lawson WB, Emsley RA, Zhang F, Baker RW, Risser RC, Namjoshi MA, Evans AR, Breier A: A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry. 2003, 60 (12): 1218-1226. 10.1001\/archpsyc.60.12.1218.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"584_CR122","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","volume":"162","author":"M Tohen","year":"2005","unstructured":"Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL: Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry. 2005, 162 (7): 1281-1290. 10.1176\/appi.ajp.162.7.1281.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"584_CR123","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","volume":"57","author":"M Tohen","year":"2000","unstructured":"Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A: Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry. 2000, 57 (9): 841-849. 10.1001\/archpsyc.57.9.841.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"584_CR124","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","volume":"160","author":"M Tohen","year":"2003","unstructured":"Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW: Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003, 160 (7): 1263-1271. 10.1176\/appi.ajp.160.7.1263.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"584_CR125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","volume":"156","author":"M Tohen","year":"1999","unstructured":"Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V: Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry. 1999, 156 (5): 702-709.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"584_CR126","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003, 60 (11): 1079-1088. 10.1001\/archpsyc.60.11.1079.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"584_CR127","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","volume":"63","author":"JM Zajecka","year":"2002","unstructured":"Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW: A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002, 63 (12): 1148-1155.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"584_CR128","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1185\/030079905X38259","volume":"21","author":"B Zhu","year":"2005","unstructured":"Zhu B, Tunis SL, Zhao Z, Baker RW, Lage MJ, Shi L, Tohen M: Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial. Curr Med Res Opin. 2005, 21 (4): 555-564. 10.1185\/030079905X38259.","journal-title":"Curr Med Res Opin"},{"key":"584_CR129","first-page":"CD004040","volume-title":"Cochrane Database Syst Rev","author":"JM Rendell","year":"2003","unstructured":"Rendell JM, Gijsman HJ, Keck P, Goodwin GM, Geddes JR: Olanzapine alone or in combination for acute mania. Cochrane Database Syst Rev. 2003, CD004040-"},{"issue":"1","key":"584_CR130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.v67n0113","volume":"67","author":"TA Ketter","year":"2006","unstructured":"Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M: Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry. 2006, 67 (1): 95-101.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"584_CR131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","volume":"66","author":"CL Bowden","year":"2005","unstructured":"Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vagero M, Svensson K: A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry. 2005, 66 (1): 111-121.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"584_CR132","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","volume":"162","author":"JR Calabrese","year":"2005","unstructured":"Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005, 162 (7): 1351-1360. 10.1176\/appi.ajp.162.7.1351.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"584_CR133","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/YIC.0b013e3280119dfb","volume":"22","author":"J Cookson","year":"2007","unstructured":"Cookson J, Keck PE, Ketter TA, Macfadden W: Number needed to treat and time to response\/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. Int Clin Psychopharmacol. 2007, 22 (2): 93-100. 10.1097\/YIC.0b013e3280119dfb.","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"584_CR134","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","volume":"45","author":"MP DelBello","year":"2006","unstructured":"DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2006, 45 (3): 305-313.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"584_CR135","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","volume":"41","author":"MP Delbello","year":"2002","unstructured":"Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002, 41 (10): 1216-1223. 10.1097\/00004583-200210000-00011.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"584_CR136","first-page":"29","volume":"22","author":"J Endicott","year":"2007","unstructured":"Endicott J, Rajagopalan K, Minkwitz M, Macfadden W: A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol. 2007, 22 (1): 29-37.","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"584_CR137","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","volume":"15","author":"RS McIntyre","year":"2005","unstructured":"McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J: Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol. 2005, 15 (5): 573-585. 10.1016\/j.euroneuro.2005.02.006.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"584_CR138","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1185\/030079905X46340","volume":"21","author":"E Vieta","year":"2005","unstructured":"Vieta E, Mullen J, Brecher M, Paulsson B, Jones M: Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin. 2005, 21 (6): 923-934. 10.1185\/030079905X46340.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"584_CR139","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","volume":"24","author":"LN Yatham","year":"2004","unstructured":"Yatham LN, Paulsson B, Mullen J, Vagero AM: Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol. 2004, 24 (6): 599-606. 10.1097\/01.jcp.0000144887.66319.2f.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"584_CR140","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","volume":"25","author":"SG Potkin","year":"2005","unstructured":"Potkin SG, Keck PE, Segal S, Ice K, English P: Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol. 2005, 25 (4): 301-310. 10.1097\/01.jcp.0000169068.34322.70.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"584_CR141","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","volume":"160","author":"PE Keck Jr.","year":"2003","unstructured":"Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G: A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry. 2003, 160 (9): 1651-1658. 10.1176\/appi.ajp.160.9.1651.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"584_CR142","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","volume":"160","author":"PE Keck Jr.","year":"2003","unstructured":"Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K: Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry. 2003, 160 (4): 741-748. 10.1176\/appi.ajp.160.4.741.","journal-title":"Am J Psychiatry"},{"key":"584_CR143","volume-title":"Efficacy of aripiprazole in acute mania. A new acute, placbo-controlled study","author":"F Yocca","year":"2003","unstructured":"Yocca F, McQuade RD, Sanchez R: Efficacy of aripiprazole in acute mania. A new acute, placbo-controlled study: San Juan, Puerto Rico. 2003"},{"issue":"4","key":"584_CR144","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/0269881106059693","volume":"20","author":"G Sachs","year":"2006","unstructured":"Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T: Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol. 2006, 20 (4): 536-546. 10.1177\/0269881106059693.","journal-title":"J Psychopharmacol"},{"issue":"1-2","key":"584_CR145","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jad.2006.05.023","volume":"96","author":"A Schaffer","year":"2006","unstructured":"Schaffer A, Zuker P, Levitt A: Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord. 2006, 96 (1-2): 95-99. 10.1016\/j.jad.2006.05.023.","journal-title":"J Affect Disord"},{"issue":"3","key":"584_CR146","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0165-0327(99)00149-4","volume":"59","author":"JD Amsterdam","year":"2000","unstructured":"Amsterdam JD, Garcia-Espana F: Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affect Disord. 2000, 59 (3): 225-229. 10.1016\/S0165-0327(99)00149-4.","journal-title":"J Affect Disord"},{"issue":"6","key":"584_CR147","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00004714-199812000-00003","volume":"18","author":"JD Amsterdam","year":"1998","unstructured":"Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C: Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol. 1998, 18 (6): 435-440. 10.1097\/00004714-199812000-00003.","journal-title":"J Clin Psychopharmacol"},{"key":"584_CR148","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0165-0327(01)00449-9","volume":"67","author":"HJ Moller","year":"2001","unstructured":"Moller HJ, Bottlender R, Grunze H, Streuss A, Wittmann J: Are antidepressant less effective in the acute treatment of bipolar I compared to unipolar depression?. J Affect Disord. 2001, 67: 141-146. 10.1016\/S0165-0327(01)00449-9.","journal-title":"J Affect Disord"},{"issue":"2","key":"584_CR149","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","volume":"163","author":"GS Leverich","year":"2006","unstructured":"Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM: Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006, 163 (2): 232-239. 10.1176\/appi.ajp.163.2.232.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"584_CR150","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1034\/j.1399-5618.2001.30505.x","volume":"3","author":"RM Post","year":"2001","unstructured":"Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA: Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord. 2001, 3 (5): 259-265. 10.1034\/j.1399-5618.2001.30505.x.","journal-title":"Bipolar Disord"},{"key":"584_CR151","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archpsyc.1976.01770090052004","volume":"33","author":"JM Himmelhoch","year":"1976","unstructured":"Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ: Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatry. 1976, 33: 1062-1066.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"584_CR152","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/ajp.157.1.124","volume":"157","author":"LT Young","year":"2000","unstructured":"Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000, 157 (1): 124-126.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"584_CR153","first-page":"1097","volume":"35","author":"RF Prien","year":"1984","unstructured":"Prien RF: NIMH report. Five-center study clarifies use of lithium, imipramine for recurrent affective disorders. Hosp Community Psychiatry. 1984, 35 (11): 1097-1098.","journal-title":"Hosp Community Psychiatry"},{"issue":"1","key":"584_CR154","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1399-5618.2003.00083.x","volume":"6","author":"JD Amsterdam","year":"2004","unstructured":"Amsterdam JD, Shults J, Brunswick DJ, Hundert M: Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate. Bipolar Disord. 2004, 6 (1): 75-81. 10.1046\/j.1399-5618.2003.00083.x.","journal-title":"Bipolar Disord"},{"issue":"3","key":"584_CR155","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1034\/j.1600-0447.2001.00383.x","volume":"104","author":"R Ramasubbu","year":"2001","unstructured":"Ramasubbu R: Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders. Acta Psychiatr Scand. 2001, 104 (3): 236-8; discusiion 238-9. 10.1034\/j.1600-0447.2001.00383.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"584_CR156","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jad.2005.02.018","volume":"87","author":"JD Amsterdam","year":"2005","unstructured":"Amsterdam JD, Shults J: Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction. J Affect Disord. 2005, 87 (1): 121-130. 10.1016\/j.jad.2005.02.018.","journal-title":"J Affect Disord"},{"issue":"5","key":"584_CR157","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v66n0511","volume":"66","author":"PE Keck Jr.","year":"2005","unstructured":"Keck PE, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M: Analyses of treatment-emergent mania with olanzapine\/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry. 2005, 66 (5): 611-616.","journal-title":"J Clin Psychiatry"},{"issue":"17","key":"584_CR158","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa064135","volume":"356","author":"GS Sachs","year":"2007","unstructured":"Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007, 356 (17): 1711-1722. 10.1056\/NEJMoa064135.","journal-title":"N Engl J Med"},{"issue":"6","key":"584_CR159","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v63n0607","volume":"63","author":"E Vieta","year":"2002","unstructured":"Vieta E, Martinez-Aran A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M: A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry. 2002, 63 (6): 508-512.","journal-title":"J Clin Psychiatry"},{"key":"584_CR160","first-page":"423","volume":"52","author":"F Rouillon","year":"1991","unstructured":"Rouillon F, Serrurier D, Miller HD, Gerard MJ: Prophylactic efficacy of maprotiline on unipolar depression relapse. J Clin Psychiatry. 1991, 52: 423-431.","journal-title":"J Clin Psychiatry"},{"key":"584_CR161","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(04)16043-1","volume":"363","author":"C Wittington","year":"2004","unstructured":"Wittington C, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E: Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. The Lancet. 2004, 363: 1341-1345. 10.1016\/S0140-6736(04)16043-1.","journal-title":"The Lancet"},{"issue":"11","key":"584_CR162","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4088\/JCP.v64n1116d","volume":"64","author":"MR Privitera","year":"2003","unstructured":"Privitera MR, Maharaj K: Mania from dose-related ziprasidone augmentation of an SSRI. J Clin Psychiatry. 2003, 64 (11): 1393-1394.","journal-title":"J Clin Psychiatry"},{"key":"584_CR163","unstructured":"FDA: http:\/\/www.fda.gov\/cder\/drug\/antidepressants\/default.htm. (accessed 16 October 2006)."},{"issue":"1","key":"584_CR164","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4088\/JCP.v67n0108","volume":"67","author":"MS Bauer","year":"2006","unstructured":"Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS: Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2006, 67 (1): 48-55.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"584_CR165","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145706006900","volume":"10","author":"J Scott","year":"2006","unstructured":"Scott J, Colom F, Vieta E: A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol. 2006, 10 (1): 123-129. 10.1017\/S1461145706006900.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"584_CR166","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1034\/j.1399-5618.2001.030208.x","volume":"3","author":"JJ Daly","year":"2001","unstructured":"Daly JJ, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Roose SP, Sackeim HA: ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 2001, 3 (2): 95-104. 10.1034\/j.1399-5618.2001.030208.x.","journal-title":"Bipolar Disord"},{"issue":"8","key":"584_CR167","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archpsyc.1988.01800320037004","volume":"45","author":"JG Small","year":"1988","unstructured":"Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, Small IF: Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988, 45 (8): 727-732.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"584_CR168","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1192\/bjp.164.6.806","volume":"164","author":"S Sikdar","year":"1994","unstructured":"Sikdar S, Kulhara P, Avasthi A, Singh H: Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry. 1994, 164 (6): 806-810.","journal-title":"Br J Psychiatry"},{"key":"584_CR169","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1034\/j.1399-5618.4.s1.41.x","volume":"4 Suppl 1","author":"OT Dolberg","year":"2002","unstructured":"Dolberg OT, Dannon PN, Schreiber S, Grunhaus L: Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord. 2002, 4 Suppl 1: 94-95. 10.1034\/j.1399-5618.4.s1.41.x.","journal-title":"Bipolar Disord"},{"issue":"1","key":"584_CR170","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1034\/j.1399-5618.2003.00011.x","volume":"5","author":"Z Nahas","year":"2003","unstructured":"Nahas Z, Kozel FA, Li X, Anderson B, George MS: Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003, 5 (1): 40-47. 10.1034\/j.1399-5618.2003.00011.x.","journal-title":"Bipolar Disord"},{"issue":"2","key":"584_CR171","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.psychres.2004.05.019","volume":"128","author":"G Saba","year":"2004","unstructured":"Saba G, Rocamora JF, Kalalou K, Benadhira R, Plaze M, Lipski H, Januel D: Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: a case series of eight patients. Psychiatry Res. 2004, 128 (2): 199-202. 10.1016\/j.psychres.2004.05.019.","journal-title":"Psychiatry Res"},{"issue":"2","key":"584_CR172","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1034\/j.1399-5618.2000.020205.x","volume":"2","author":"J Levine","year":"2000","unstructured":"Levine J, Chengappa KN, Brar JS, Gershon S, Yablonsky E, Stapf D, Kupfer DJ: Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord. 2000, 2 (2): 120-130. 10.1034\/j.1399-5618.2000.020205.x.","journal-title":"Bipolar Disord"},{"issue":"4","key":"584_CR173","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1399-5618.2001.30401.x","volume":"3","author":"PZ Lim","year":"2001","unstructured":"Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M: Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord. 2001, 3 (4): 165-173. 10.1034\/j.1399-5618.2001.30401.x.","journal-title":"Bipolar Disord"},{"issue":"1-3","key":"584_CR174","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jad.2006.01.032","volume":"93","author":"F Colom","year":"2006","unstructured":"Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J: Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 2006, 93 (1-3): 13-17. 10.1016\/j.jad.2006.01.032.","journal-title":"J Affect Disord"}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-6-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1744-859X-6-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-6-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T12:19:40Z","timestamp":1708258780000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/1744-859X-6-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,9]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/1744-859x-6-27","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,9]]},"article-number":"27"}}